Lab21 among First to Offer FDA Approved Companion Diagnostic in the US
05:23 EDT 12 Jul 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Lab21 Limited, the global specialist in personalized medicine and
clinical diagnostics is pleased to announce that its CLIA laboratory in
Greenville, South Carolina, has been named as one of nine laboratories
in the US to offer ...
Other Sources for this Article
Lab21
Graham Mullis, CEO
Michael Bolick, President,
Lab21 Inc.
Mike Annable, Divisional Director – Clinical Laboratory
t:
+44 (0)1223 395450
e:graham.mullis@lab21.com
michael.bolick@lab21.com
mike.annable@lab21.com
or
For
media and investor enquiries:
College Hill
Nicole
Yost/Gemma Howe
t: +44 (0)20 7457 2020
e: lab21@collegehill.com
More From BioPortfolio on "Lab21 among First to Offer FDA Approved Companion Diagnostic in the US"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
